Cells displaying highly condensed pyknotic nuclei, the most characteristic feature of apoptosis, are considered as dead cells in neural tissue. The present study aimed to devise methods that could allow the neurogenetic and phenotypic characterization of dying pyknotic cells. In the first set of experiments, pregnant mice were labeled at embryonic days E10-El6 with pulses of 5'-bromodeoxyuridine (BrdU). Offspring were processed for the immunocytochemical visualization of BrdU after an immunoperoxidase reaction. In addition to normal, healthy immunopositive nuclei, these preparations displayed a number of pyknotic nuclei that were immunoreactive for BrdU. Both the regional and the temporal distribution of BrdU-positive pyknotic cells were coincidental with the peaks of dead cells in neural tissue. For example, pulses of BrdU at E10-E11 resulted in the visualization of immunoreactive pyknotic cells in the subplate and white matter of the cerebral cortex in early postnatal (P) animals. Thus, the times of generation (birthdates) of cells subjected to degenerative processes can be unequivocally identified. In the second set of experiments, brain sections from unlabeled littermates were immunostained for a variety of neural and glial markers and counterstained with bisbenzimide, to find antigens which, by being present in degenerate pyknotic cells, could indicate the phenotype of such cells. Although no pyknotic cells were positively immunostained for neurofilaments, neuropeptide Y, somatostatin, vasoactive intestinal polypeptide, or vimentin, a number of pyknotic cells were found to be immunoreactive for microtubuleassociated protein 2, gamma-aminobutyric acid, calbindin 28KD, and glial fibrillary acidic protein. The percentage of pyknotic cells labeled with neural antigens accounted for more than 20% of the total number of pyknotic cells in a given brain region. In contrast, GFAPpositive pyknotic cells represented up to 50°/o of the total pyknotic cell population. The method shown here has enabled us to determine that both neurons and glial cells undergo degeneration during normal development. (JZ5scochem Cycochem 41:819-827, 1993) 
Introduction
During neural development, regressive phenomena have an important role in building up the pattern of cytoarchitectonics and synaptic connections of the adult brain (e.g., Cowan et al., 1984) . The most common regressive events are axonal pruning and elimination of exuberant synaptic connections (e.g., O'Leary, 1992; Innocenti, 1981) and the h e n c e uf ephemeral, transient neuron populations that undergo cell death in precise developmental periods. Naturally occurring cell death in neural tissue is a widespread Supported phenomenon during neuronal development and is believed to play a role in shaping gross morphology, regulating adult cell numbers, cytoarchitectonic refinement, and in the elimination of aberrant neuronal connections (see Oppenheim, 1991, for review) . Moreover, recent evidence has shown that certain transient neuronal populations are essential for the formation of neural networks by providing guiding and targeting cues necessary for the establishment of the axon pathway. Striking examples of such a role are the subplate neuronal population of the developing cerebral cortex, which is essential for the formation of appropriate thalamocortical relationships (Shatz, 1992; Antonini and Shatz, 1990; McConnell et al., 1989; Luskin and Shatz, 1985) . and the many examples of guidepost cells in invertebrates (Palka et al., 1992) .
As discussed recently, the analysis of naturally occurring neuronal cell death is hampered by a lack of appropriate methods with which to study either the onset of cell death or the characterization of the cell populations involved in such degenerative processes (Oppenheim, 1991) . In most studies, neuronal cell death has been inferred from decreased cell counts during development (Heumann and Leuba, 1983) or by assessing a reduction in the number of cells labeled after [3H]-thymidine pulses (Clarke, 1990; Clarke et al., 1976) . In other studies, the presence and distribution of cells displaying pyknotic nuclei, the most characteristic feature of apoptosis (Ferrer et al., 1992; Clarke, 1990; Finlay and Pallas, 1989; Finlay and Slattery, 1983; Hamburger et al., 1981) , has been determined. Even in that case, no method is available for phenotypic characterization of the cell populations subjected to degeneration. In this vein, a major issue of controversy is whether dying pyknotic cells correspond to neurons or glial cells, since the latter have also been shown to undergo cell degeneration (Oppenheim, 1991; Hankin et al., 1988) .
A possible strategy to detect and characterize dead cells involves the mapping of putative cell death markers, e.g., stress-related proteins, which may be overexpressed in cell degeneration conditions (Gonzalez Martin et al., 1991; Valverde et al., 1990; AI-Ghoul and Miller, 1989; Wolozin et al. 1988 ). To date, however, their application to the developmental analysis of the vertebrate brain has been controversial to some extent, since most of these proteins have been shown to be expressed during normal ontogenesis in presumably healthy cells.
The approach chosen in the present study is directed to devising methods that could allow the characterization of dying pyknotic cells. First, we show the presence of pyknotic cells that display immunoreactivity for S'-bromodeoxyuridine (BrdU) (Soriano and Del Rio, 1991; Del Rio and Soriano, 1989; Miller and Nowakowski, 1988; Hoshino et al., 1985) after receiving a pulse injection of the thymidine analogue at a given embryonic stage. Because of the inability of post-mitotic neurons to reenter the mitotic cycle, pulses of BrdU are currently used to determine the times of generation (birthdates) of neurons, i.e., the day on which neuroblasts undergo their last cell division and leave the ventricular zone. In this way, the birthdates of cells subjected to degenerative processes can be unequivocally identified. Secondly, we combine DNA-specific staining for the visualization of pyknotic nuclei with a wide range of neural and glial antigens, to find cell markers which, by being present in degenerating or dying cells, could indicate the phenotype of such cells.
Materials and Methods
Animals. A total of 22 NMRI mice (Iffa Credo; Lyon, France) from our breeding colony were used in the present study. The animals used for BrdU immunostaining derived from five pregnant females that were injected IP with a single pulse of BrdU (50 mg/kg bw; 10 mg/ml dissolved in 0.1 M Tris-HCI buffered saline, pH 7.6) at embryonic days E10, Ell, E12, or E16 (see details in Soriano and Del Rio, 1991; Del Rio and Soriano, 1989 ). The mating day was considered as EO. Two additional, unlabeled littermates were used for the combined visualization of neural antigens and DNA staining. The animals were killed between postnatal days 0 (PO, day of birth), and P8, when cell death is maximal in telencephalic and diencephalic regions (Ferrer et al., 1990 (Ferrer et al., ,1992  Finlay and Pallas, 1989;  Finlay and Slattery, 1983 ).
BrdU Immunohistochemistry. After deep ether anesthesia, animals were perfused with saline to wash out blood cells, and brains were dissected out and fixed in Carnoy's solution for 2-10 days. Brains were embedded in paraffin and coronally sectioned at a thickness for 10 pm. After dewaxing. sections were processed for the immunocytochemical visualization of BrdU essentially as described (Soriano and Del Rio, 1991; Del Rio and Soriano, 1989) . Briefly, sections were deproteinized with cold 0.1 N HCI(10 min), treated with 2 N HCI in 0.05 M PBS at 37'C to denature DNA, and neutralized with 0.1 M borate buffer (pH 8.5). After pre-incubation in 10% normal horse serum, 0.2 M lysine, and 0.2 M glycine for 2 hr, sections were sequentially incubated with a monoclonal anti-BrdU antibody [(Magaud and Mason, 1988) clone BuZOa, diluted 1:75, overnight], biotinylated horse anti-mouse secondary antibody (diluted 1:200, 2 hr), and avidin-biotin-peroxidase complex (ABC) (Vector Labs, Burlingame, CA) (diluted 1:2OO, 2 hr). Immunoreagents were diluted in 0.1 M PBS, 0.1% Triton X-100, and 5% normal horse serum. Peroxidase activity was developed with 0.03% diaminobenzidine tetrahydrochloride, 0.2 % nickel ammonium sulfate. and 0.005% H202 (DAB-Ni), a reaction that renders the immunoreaction endproduct black (Hancock, 1982) . After immunostaining, sections were counterstained with hematoxylin and coverslipped with Eukitt (Merck; Darmstadt, Germany).
In some cases, BrdU was visualized after an indirect immunofluorescence procedure in which sections were treated as above except that the primary monoclonal antibody was used at a 1:20 dilution and a fluoresceinconjugated goat anti-mouse antibody (dilution 1:30) (Boehringer Mannheim; Kvistgard, Germany) was used to detect the primary bound antibody. Sections were counterstained with the DNA-specific marker propidium iodide (10 pg/ml in PBS) for 10 min and mounted in fluorescence mounting medium. After the BrdU immunostaining process, bisbenzimide staining did not give satisfactory results Bisbenzimide Staining in Combination with Neural Antigen Immunohistochemistry. Animals were transcardidly perfused with 4% paraformaldehyde dissolved in 0.1 M phosphate buffer (pH 7.2-7.4) after deep ether anesthesia. The brains were removed and immersed in the same fixative overnight. After cryoprotection in 30% sucrose-0.1 M phosphate buffer, brains were frozen in dry ice and sectioned at 50 pm in a freezing microtome. For the immunocytochemical detection of y-aminobutyric acid (GABA), animals were perfused with the same fixative as above but containing 0.25% glutaraldehyde, and the brains were sectioned with a vibratome (Lancer). Sections were washed, treated with 10% methanol and 3% hydrogen peroxide (10 min) to inhibit endogenous peroxidases, and processed for immunohistochemistry. After blocking with a solution containing 10% normal serum, 0.2 M glycine, 0.2 M lysine, and 0.2% gelatin, sections were incubated overnight in one of the following primary antibodies: rabbit anti-GABA (diluted 1:3000) (Immunotech; Marseille, France) (Seguela et al., 1984) ; mouse anti-microtubule-associated protein 2 (MAP2, diluted 1:3000, clone SMI52) (Sternberger-Meyer; Jarretsville, MD); mouse anti-calbindin 2 8 m (CALB, diluted 1:5000, clone 300) (Celio et al., 1990) ; rabbit antineuropeptide Y (NPY, I I (clone SMI34); (Sternberger-Meyer); rabbit anti-somatostatin (SS, diluted 12300) (Dakopatts; Glostmp, Denmark); rabbit anti-glial fibrillary acidic protein (GFAP, diluted 1:lOOO) (Dakopatts); or mouse anti-vimentin (VIM, diluted l:>O, clone V9) (Dakopatts) (Osborn et al., 1984) . Primary antibodies were detected with the corresponding ABC peroxidase kits as described by the manufacturer (Vector Labs). After peroxidase development with 0.03% DAB and 0.01% H202, sections were counterstained with the DNA-specific marker bisbenzimide (Hoechst 33342; Somerville, NJ) (10 Wglml in PBS, 20 min) and coverslipped. For the immunocytochemical detection of neural antigens by indirect immunofluorescence, the above primary antibodies were concentrated fourfold and fluorescein-labeled secondary antibodies [(diluted 1:30; goat anti-mouse IgG, F(ab)z fragment) (Boehringer Mannheim) or sheep anti-rabbit IgG (Dakopatts)] were used. Sections were mounted with fluorescence mounting medium after bisbenzimide staining. Sections were examined in a Polivar I1 (Reichert) microscope equipped with epifluorescence. In some cases combined, epifluorescence and transmitted brightfield illumination were used.
Controls. Immunocytochemical controls, in which either the primary anti-BrdU or anti-neuronal and glial antigens were omitted or substituted by normal serum, did not reveal positive immunostaining.
Results

Visualization of BrdU-immunoreactive Pyknotic Cells
Paraffin sections immunostained for BrdU displayed a large number of BrdU-positive nuclei (Figure 1 ). Owing to the DAB-Ni development, BrdU-immunoreactive nuclei appeared black and were easily distinguished from the non-immunoreactive nuclei counterstained with hematoxylin. Heavily and lightly stained nuclei ( Figures  IA, ID, 2B and 2C) , probably representing dilution of the thymidine analogue in successive mitotic divisions (Soriano and Del Rio, 1991; Del Rio and Soriano, 1989) , were also observed. Some hematoxylin-stained cells displayed the morphological features characteristic of pyknotic degenerate cells, i.e., an extremely condensed, often fragmented nucleus surrounded by a thin rim of cytoplasm (Ferrer et al., 1992; Clarke, 1990; Finlay and Slattery, 1983) . On occasion, cells exhibiting these distinctive characteristics were found to be immunoreactive for BrdU. As for the healthy cells described above, the BrdU immunoreaction endproduct in pyknotic cells was confined to the condensed nucleus, whereas the cytoplasm remained unstained. Examples illustrating BrdU-positive pyknotic cells are shown in Figures 1A-1D . A perusal of our preparations revealed an uneven distribution of BrdU-positive immunoreactive cells that depended on the embryonic day of labeling by the pulse of BrdU and on the developmental stage analyzed. For example, pulses of BrdU at ElO-Ell resulted in relatively large numbers of immunoreactive pyknotic cells in the subplate and developing white matter of the cerebral cortex in animals aged PO-P5 ( Figures 1A and  1B) . These results are in agreement with current data indicating that transient cell populations in the subplate and white matter are among the earliest generated cells in the cortex (E10-E11 in mouse) (Ferrer et al., 1992; Wood et al., 1992) and die during the first postnatal weeks (Shatz et al., 1988; Luskin and Shatz, 1985) . Other examples illustrating pyknotic cells immunoreactive for BrdU in thalamus and in striatum, which were labeled after BrdU injections at E10 and El6, respectively, are shown in Figures 1C and 1D .
To further substantiate that the immunostaining of pyknotic cells corresponded to BrdU incorporated into the cell nucleus and was not the result of artifact, sections were immunostained for BrdU by an immunofluorescence procedure and counterstained with the DNA-specific marker propidium iodide ( Figures 1E-1H) . These experiments demonstrated unequivocally that the cell substrate immunostained for BrdU in pyknotic cells is actually DNA, which therefore rules out the possibility of translocation or incorporation of BrdU into other cell compartments.
Visualization of Neuronal and Glial Antigens in Pyknotic Cells
To determine whether pyknotic cells were immunoreactive for neuronal or glial markers, sections from Po-P8 animals were immunostained for several antigens using fluorescein-tagged secondary antibodies or an immunoperoxidase reaction and thereafter were counterstained with bisbenzimide. As shown in Figures 2 and 3 , immunoreactive pyknotic cells could be identified either by immunofluorescence or in immunoperoxidase-processed material by combining transmitted brightfield illumination and epifluorescence. In immunoperoxidase-reacted material no pyknotic cells were stained with antibodies against NFL or neuropeptides (NPY, SS, VIP), irrespective of the developmental period or region studied. In contrast, pyknotic cells exhibited immunoreactivity for MAP2, a widely distributed neuronal marker (Figures 2A, 2B, 3C , and 3D). MAP2-positive pyknotic cells never accounted for more than 20% of the total number of pyknotic cells in a given brain region. A few pyknotic cells were also seen to be positively stained with GABA ( Figures 3G and 3H ) and calbindin 28KD (Figures 2C  and 2D ) antibodies. The same results were obtained when an immunofluorescence procedure was used ( Figures 2C, 2D , 3A, and 3B). Normally, the immunoreaction endproduct for MAP2, GABA, and calbindin 28KD was confined to a thin rim of cytoplasm that surrounded the condensed pyknotic nucleus. In a few cases, however, a somewhat larger cytoplasm was noted (Figures 2A, 2B, 3G , and 3H). No labeled dendrites or cell processes were seen to arise from the immunoreactive pyknotic cells with any of the antibodies tested. When sections were immunostained with glial markers, only GFAP-immunoreactive pyknotic cells were observed (Figures 2E,  2F , 3E, 3F, and 31-3K) with either immunofluorescence or immunoperoxidase procedures. The number of pyknotic cells display- 
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A 3 H ing GFAP immunoreactivity was found in some cases to be very high, reaching percentages close to 50% of the total population of pyknotic cells. Although in most cases immunoreaction for GFAP in pyknotic cells was restricted to a thin cytoplasm around the condensed nucleus (Figures 31-3K) , some immunoreactive pyknotic cells displayed GFAP-positive elongations and processes (Figures 2E,  2F, 3E, and 3F) , similar to what is found in normal, healthy astroglial cells.
Discussion
As mentioned in the Introduction, the analysis of cell death in neural tissue has often been hampered by a lack of appropriate methodology either to assess the onset of cell degeneration or to characterize the cell populations actually involved in cell death (Oppenheim, 1991) . One of the procedures used consists of the labeling of a given generation of post-mitotic neurons by pulses of [ 3H]-thymidine and the subsequent counting of radioactively labeled cells at different developmental periods (Clarke, 1990; Clarke et al., 1976) . This procedure is based on the inability of post-mitotic neurons to reenter the cell cycle and the subsequent loss of their nuclear [3H]thymidine labeling. The present study, showing BrdU-positive pyknotic nuclei, offers a more direct approach by directly determining the time of generation (birthdate) of dying pyknotic cells. The possibility that BrdU immunoreaction products in pyknotic cells could correspond to cell structures other than DNA (e.g., phagosomes) was ruled out by combining DNA-specific dyes and BrdU immunostaining.
[ 3H]-Thymidine-labeled pyknotic cells have not been reported to our knowledge, probably because the lower resolution of the autoradiographic technique does not allow autoradiographic silver grains to be related to the small pyknotic cells. BrdU immunostaining not only permits identification of birthdates of particular cell populations (Soriano and Del Rio, 1991; Del Rio and Soriano, 1989; Miller and Nowakowski, 1988) but also allows the period of death of such populations to be determined because of their higher microscopic resolution. A recent study suggests that degenerate dying cells can incorporate small amounts of [3H]thymidine during their degenerative phase (Clarke and Hornung, 1989) . The possibility that the BrdU-positive pyknotic cells detected in the present study may have been labeled by similar mechanisms can be ruled out, since BrdU was administered at least 1 week before immunostaining, and BrdU is available for incorporation into DNA only during a short period of time after a given pulse injection.
The second set of experiments was aimed at determining whether dying cells, identified by their pyknotic nuclei, could be phenotypically characterized by the presence of a number of glial or neural antigens. Our results show that pyknotic cells having immunoreactive cytoplasm can be visualized either by double-fluorescence optics or by combined fluorescence and brightfield illumination on immunoperoxidase preparations. With this approach we were able to show pyknotic cells immunoreactive for GFAP, MAP2, CALB, and GABA, but no pyknotic cell appeared to be immunoreactive for NFL, VIM, or any of the neuropeptides tested. This is surprising because the neuropeptide-containing neuronal populations of the cerebral cortex are among those most likely to undergo cell degeneration. Developmental immunocytochemical studies for NPY, VIP, and SP (Ferrer et al., 1992; Del Rio et al., 1991; Wahle, 1990; Wahle and Meyer, 1987) have provided evidence for the existence of neuron populations that exhibit abnormal morphological features, such as extremely beaded and varicose swollen processes or protruding cell bodies, which have been interpreted as signs of neuronal degeneration. In our material we found immunostained neurons displaying these abnormal features, especially with anti-NPY antibodies. These cells, however, displayed normal, apparently healthy nuclei with bisbenzimide staining. One possible explanation for the lack of pyknotic nuclei in neuropeptide-immunopositive populations is that the neuropeptide is no longer present in cells reaching advanced stages of cell degeneration that include the presence of pyknotic nuclei. In fact, calcium-activated proteases, which are believed to participate in cell death mechanisms (Iacopino and Christakos, 1990; Rich and Hollowell, 1990) , may break down neuropeptide molecules, thus diminishing or abolishing their recognition by the antibodies used. It is also important to note that neuropeptide-positive neurons account for a very small percentage of the total neuron population in the cerebral cortex (e.g., Pamavelas, in press), which may have hindered the identifation ufneuropeptideimmunopositive pyknotic cells.
Our immunocytochemical results show that some cytoskeletal proteins (MAP-2, GFAP), calcium-binding proteins (CALB), and neurotransmitters (GABA) are present in at least some pyknotic cells. These results indicate either that these molecules are among the last to be degraded by proteases or that, although partially destroyed by cell degeneration processes, they retain the epitopes detected by the antibodies used.
The morphology of immunoreactive pyknotic cells in the present study mainly corresponded to previous descriptions that define pyknotic cells as having a reduced, almost absent cytoplasm with no apparent cell elongations (Ferrer et al., 1992; Clarke, 1990; Finlay and Slattery, 1983) . In some cases, however, we noted the presence of pyknotic cells presenting a larger cytoplasmic area, and even GFAP-positive elongations. This can be explained if we take into account that apoptosis takes some hours to occur and that pyknotic cells may be present in tissue for a longer time before being removed by phagocytosis (Ferrer et al., 1990 (Ferrer et al., ,1992 Clarke, 1990) . Therefore, the identification of pyknotic nuclei probably results in the visualization of cells in different "stages" of cell death. It would therefore be possible that some "early" pyknotic cells retain some processes and a larger amount of cytoplasm than the "late" pyknotic cells in a more advanced degenerative phase.
Our data demonstrating GFAP-, CALB-, GABA-, and MAP2- positive cells indicate that glial and neural cells undergo cell degeneration during normal development. Our preliminary data, however, show that the number of MAP2-positive pyknotic cells is relatively low (maximum percentage 20%), whereas GFAP-positive glial cells are more abundant, sometimes representing up to 50% of the total pyknotic cell population in a given brain area (e.g., cerebral cortex). This may indicate that most of the naturally occurring cell death reported for the cortex, especially that found in upper supragranular layers (Ferrer et al., 1990 (Ferrer et al., ,1992 Finlay and Slattery, 1983) . actually corresponds to glial cell degeneration. An alternative explanation is that MAP2 immunoreactivity may be present only in initial phases of cell death, therefore resulting in an underestimation of the actual number of neurons containing pyknotic nuclei. Quantitative studies on the rate of glial and neuronal cell death during normal cortical development are at present being pursued in our laboratory to resolve this issue. In summary, the present report describes a simple method to study the characteristics of dead cells in brain development by combining DNA-specific staining with immunostaining for BrdU or a variety of glial and neuronal antigens. Potential uses of this methodology include the determination of the generations of post-mitotic cells subjected to naturally occurring cell death during normal development and the characterization of glial and neuronal phenotypes in such populations. The same methodological approach can also be used to characterize cells in the adult brain susceptible to stimulus-inducible cell death.
